# Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

> **NCT03809689** · NA · TERMINATED · sponsor: **University of Lausanne Hospitals** · enrollment: 24 (actual)

## Conditions studied

- Myocardial Infarction, Acute
- Myocardial Reperfusion
- Chronic Ischemic Heart Disease

## Interventions

- **OTHER:** 68Ga-NODAGA-RGD PET/CT
- **DIAGNOSTIC_TEST:** 82-Rb PET/CT as part of standard care, not a comparator

## Key facts

- **NCT ID:** NCT03809689
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-10-11
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809689, "Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03809689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*